Skip to main content
Erschienen in: Supportive Care in Cancer 6/2014

01.06.2014 | Original Article

Metastatic epidural spinal cord compression among elderly patients with advanced prostate cancer

verfasst von: Benjamin A. Spencer, Jin Joo Shim, Dawn L. Hershman, Brad E. Zacharia, Emerson A. Lim, Mitchell C. Benson, Alfred I. Neugut

Erschienen in: Supportive Care in Cancer | Ausgabe 6/2014

Einloggen, um Zugang zu erhalten

Abstract

Background

A recent randomized trial demonstrated that for metastatic epidural spinal cord compression (MESCC), a complication of advanced prostate cancer, surgical decompression may be more effective than external beam radiation therapy (RT). We investigated predictors of MESCC, its treatment, and its impact on hospital length of stay for patients with advanced prostate cancer.

Methods

We used the SEER-Medicare database to identify patients >65 years with stage IV (n = 14,800) prostate cancer. We used polytomous logistic regression to compare those with and without MESCC and those hospitalized for treatment with surgical decompression and/or RT.

Results

MESCC developed in 711 (5 %) of patients, among whom 359 (50 %) received RT and 107 (15 %) underwent surgery ± RT. Median survival was 10 months. MESCC was more likely among patients who were black (OR 1.75, 95 %CI 1.39–2.19 vs. white) and had high-grade tumors (OR 3.01, 95 %CI 1.14–7.94), and less likely in those younger; with prior hormonal therapy (OR 0.73, 95 %CI 0.62–0.86); or with osteoporosis (OR 0.63, 95 %CI 0.47–0.83). Older patients were less likely to undergo either RT or surgery, as were those with ≥1 comorbidity. Patients with high-grade tumors were more likely to undergo RT (OR 1.92, 95 %CI 1.25–2.96). Those who underwent RT or surgery spent an additional 11 and 29 days, respectively, hospitalized.

Conclusions

We found that black men with metastatic prostate cancer are more likely to develop MESCC than whites. RT was more commonly utilized for treatment than surgery, but the elderly and those with comorbidities were unlikely to receive either treatment.
Literatur
1.
2.
Zurück zum Zitat Bubendorf L, Schopfer A, Wagner U et al (2000) Metastatic patterns of prostate cancer: an autopsy study of 1,589 patients. Hum Pathol 31(5):578–583PubMedCrossRef Bubendorf L, Schopfer A, Wagner U et al (2000) Metastatic patterns of prostate cancer: an autopsy study of 1,589 patients. Hum Pathol 31(5):578–583PubMedCrossRef
4.
Zurück zum Zitat George R, Jeba J, Ramkumar G, Chacko AG, Leng M, Tharyan P (2008) Interventions for the treatment of metastatic extradural spinal cord compression in adults. The Cochrane Database of Systematic Reviews. (4):CD006716 George R, Jeba J, Ramkumar G, Chacko AG, Leng M, Tharyan P (2008) Interventions for the treatment of metastatic extradural spinal cord compression in adults. The Cochrane Database of Systematic Reviews. (4):CD006716
5.
Zurück zum Zitat Patchell RA, Tibbs PA, Regine WF et al (2005) Direct decompressive surgical resection in the treatment of spinal cord compression caused by metastatic cancer: a randomised trial. Lancet 366(9486):643–648PubMedCrossRef Patchell RA, Tibbs PA, Regine WF et al (2005) Direct decompressive surgical resection in the treatment of spinal cord compression caused by metastatic cancer: a randomised trial. Lancet 366(9486):643–648PubMedCrossRef
6.
Zurück zum Zitat Du XL, Fang S, Vernon SW et al (2007) Racial disparities and socioeconomic status in association with survival in a large population-based cohort of elderly patients with colon cancer. Cancer 110(3):660–669PubMedCrossRef Du XL, Fang S, Vernon SW et al (2007) Racial disparities and socioeconomic status in association with survival in a large population-based cohort of elderly patients with colon cancer. Cancer 110(3):660–669PubMedCrossRef
7.
Zurück zum Zitat Charlson ME, Pompei P, Ales KL, MacKenzie CR (1987) A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J chronic dis 40(5):373–383PubMedCrossRef Charlson ME, Pompei P, Ales KL, MacKenzie CR (1987) A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J chronic dis 40(5):373–383PubMedCrossRef
8.
Zurück zum Zitat Klabunde CN, Potosky AL, Legler JM, Warren JL (2000) Development of a comorbidity index using physician claims data. J Clin Epidemiol 53(12):1258–1267PubMedCrossRef Klabunde CN, Potosky AL, Legler JM, Warren JL (2000) Development of a comorbidity index using physician claims data. J Clin Epidemiol 53(12):1258–1267PubMedCrossRef
9.
Zurück zum Zitat Hoffman RM, Gilliland FD, Eley JW et al (2001) Racial and ethnic differences in advanced-stage prostate cancer: the Prostate Cancer Outcomes Study. J Natl Cancer Inst 93(5):388–395PubMedCrossRef Hoffman RM, Gilliland FD, Eley JW et al (2001) Racial and ethnic differences in advanced-stage prostate cancer: the Prostate Cancer Outcomes Study. J Natl Cancer Inst 93(5):388–395PubMedCrossRef
10.
Zurück zum Zitat Polednak AP (2003) Black-white differences in survival from late-stage prostate cancer. Ethn Dis 13(2):220–225PubMed Polednak AP (2003) Black-white differences in survival from late-stage prostate cancer. Ethn Dis 13(2):220–225PubMed
11.
Zurück zum Zitat Tangen CM, Hussain MH, Higano CS et al (2012) Improved overall survival trends of men with newly diagnosed M1 prostate cancer: a SWOG phase III trial experience (S8494, S8894 and S9346). The Journal of urology 188(4):1164–1169PubMedCentralPubMedCrossRef Tangen CM, Hussain MH, Higano CS et al (2012) Improved overall survival trends of men with newly diagnosed M1 prostate cancer: a SWOG phase III trial experience (S8494, S8894 and S9346). The Journal of urology 188(4):1164–1169PubMedCentralPubMedCrossRef
12.
Zurück zum Zitat Morgans AK, Smith MR, O’Malley AJ, Keating NL (2013) Bone density testing among prostate cancer survivors treated with androgen-deprivation therapy. Cancer 119(4):863–870PubMedCentralPubMedCrossRef Morgans AK, Smith MR, O’Malley AJ, Keating NL (2013) Bone density testing among prostate cancer survivors treated with androgen-deprivation therapy. Cancer 119(4):863–870PubMedCentralPubMedCrossRef
13.
Zurück zum Zitat Freedland SJ, Richhariya A, Wang H, Chung K, Shore ND (2012) Treatment patterns in patients with prostate cancer and bone metastasis among US community-based urology group practices. Urology 80(2):293–298PubMedCrossRef Freedland SJ, Richhariya A, Wang H, Chung K, Shore ND (2012) Treatment patterns in patients with prostate cancer and bone metastasis among US community-based urology group practices. Urology 80(2):293–298PubMedCrossRef
14.
Zurück zum Zitat Loblaw DA, Laperriere NJ, Mackillop WJ (2003) A population-based study of malignant spinal cord compression in Ontario. Clin Oncol 15(4):211–217CrossRef Loblaw DA, Laperriere NJ, Mackillop WJ (2003) A population-based study of malignant spinal cord compression in Ontario. Clin Oncol 15(4):211–217CrossRef
15.
Zurück zum Zitat van den Bent MJ (2005) Surgical resection improves outcome in metastatic epidural spinal cord compression. Lancet 366(9486):609–610PubMedCrossRef van den Bent MJ (2005) Surgical resection improves outcome in metastatic epidural spinal cord compression. Lancet 366(9486):609–610PubMedCrossRef
16.
Zurück zum Zitat Chi JH, Gokaslan Z, McCormick P, Tibbs PA, Kryscio RJ, Patchell RA (2009) Selecting treatment for patients with malignant epidural spinal cord compression-does age matter? Results from a randomized clinical trial. Spine 34(5):431–435PubMedCrossRef Chi JH, Gokaslan Z, McCormick P, Tibbs PA, Kryscio RJ, Patchell RA (2009) Selecting treatment for patients with malignant epidural spinal cord compression-does age matter? Results from a randomized clinical trial. Spine 34(5):431–435PubMedCrossRef
17.
Zurück zum Zitat Loblaw DA, Mitera G, Ford M, Laperriere NJ (2012) A 2011 updated systematic review and clinical practice guideline for the management of malignant extradural spinal cord compression. Int J Radiat Oncol Biol Physics 84(2):312–317CrossRef Loblaw DA, Mitera G, Ford M, Laperriere NJ (2012) A 2011 updated systematic review and clinical practice guideline for the management of malignant extradural spinal cord compression. Int J Radiat Oncol Biol Physics 84(2):312–317CrossRef
18.
Zurück zum Zitat Thomas KC, Nosyk B, Fisher CG et al (2006) Cost-effectiveness of surgery plus radiotherapy versus radiotherapy alone for metastatic epidural spinal cord compression. Int J Radiat Oncol Biol Physics 66(4):1212–1218CrossRef Thomas KC, Nosyk B, Fisher CG et al (2006) Cost-effectiveness of surgery plus radiotherapy versus radiotherapy alone for metastatic epidural spinal cord compression. Int J Radiat Oncol Biol Physics 66(4):1212–1218CrossRef
19.
Zurück zum Zitat Hagiwara M, Delea TE, Saville MW, Chung K ( 2012) Healthcare utilization and costs associated with skeletal-related events in prostate cancer patients with bone metastases. Prostate Cancer Prostatic Dis. Nov 13 Hagiwara M, Delea TE, Saville MW, Chung K ( 2012) Healthcare utilization and costs associated with skeletal-related events in prostate cancer patients with bone metastases. Prostate Cancer Prostatic Dis. Nov 13
Metadaten
Titel
Metastatic epidural spinal cord compression among elderly patients with advanced prostate cancer
verfasst von
Benjamin A. Spencer
Jin Joo Shim
Dawn L. Hershman
Brad E. Zacharia
Emerson A. Lim
Mitchell C. Benson
Alfred I. Neugut
Publikationsdatum
01.06.2014
Verlag
Springer Berlin Heidelberg
Erschienen in
Supportive Care in Cancer / Ausgabe 6/2014
Print ISSN: 0941-4355
Elektronische ISSN: 1433-7339
DOI
https://doi.org/10.1007/s00520-013-2112-0

Weitere Artikel der Ausgabe 6/2014

Supportive Care in Cancer 6/2014 Zur Ausgabe

Alphablocker schützt vor Miktionsproblemen nach der Biopsie

16.05.2024 alpha-1-Rezeptorantagonisten Nachrichten

Nach einer Prostatabiopsie treten häufig Probleme beim Wasserlassen auf. Ob sich das durch den periinterventionellen Einsatz von Alphablockern verhindern lässt, haben australische Mediziner im Zuge einer Metaanalyse untersucht.

Mammakarzinom: Senken Statine das krebsbedingte Sterberisiko?

15.05.2024 Mammakarzinom Nachrichten

Frauen mit lokalem oder metastasiertem Brustkrebs, die Statine einnehmen, haben eine niedrigere krebsspezifische Mortalität als Patientinnen, die dies nicht tun, legen neue Daten aus den USA nahe.

Labor, CT-Anthropometrie zeigen Risiko für Pankreaskrebs

13.05.2024 Pankreaskarzinom Nachrichten

Gerade bei aggressiven Malignomen wie dem duktalen Adenokarzinom des Pankreas könnte Früherkennung die Therapiechancen verbessern. Noch jedoch klafft hier eine Lücke. Ein Studienteam hat einen Weg gesucht, sie zu schließen.

Viel pflanzliche Nahrung, seltener Prostata-Ca.-Progression

12.05.2024 Prostatakarzinom Nachrichten

Ein hoher Anteil pflanzlicher Nahrung trägt möglicherweise dazu bei, das Progressionsrisiko von Männern mit Prostatakarzinomen zu senken. In einer US-Studie war das Risiko bei ausgeprägter pflanzlicher Ernährung in etwa halbiert.

Update Onkologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.